Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adductor canal block for recovery after ACL reconstruction in pediatric patients
NCT06875427Phase 3Recruiting
- Start
- Jul 2025
- Primary completion
- Jan 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of ropivacaine, dexmedetomidine in anterior cruciate ligament injury. Started Jul 2025; status: recruiting.
02
Drugs
ropivacainedexmedetomidine
03
Conditions
anterior cruciate ligament injury
Beyond the preview
Go deeper on NCT06875427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06875427.